AU Patent

AU2021321539A1 — Compositions and methods for treating metabolic dysregulation

Assigned to Response IP Holding Co LLC · Expires 2023-03-02 · 3y expired

What this patent protects

In certain embodiments, the present disclosure relates to compositions comprising a compound that modulates the activity of microsomal triglyceride transfer protein (MTP), and therapeutic methods of using such compositions.

USPTO Abstract

In certain embodiments, the present disclosure relates to compositions comprising a compound that modulates the activity of microsomal triglyceride transfer protein (MTP), and therapeutic methods of using such compositions.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021321539A1
Jurisdiction
AU
Classification
—
Expires
2023-03-02
Drug substance claim
No
Drug product claim
No
Assignee
Response IP Holding Co LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.